Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example

by Nyhuis Allen W, Faries Douglas E, Ascher-Svanum Haya
Published 2009-05-01

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

by Zhao Zhongyun, Stensland Michael, Ascher-Svanum Haya, Kinon Bruce J
Published 2005-01-01

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials

by Liu Lin, Ascher-Svanum Haya, Stauffer Virginia, Ball Tamara, Conley Robert
Published 2009-03-01

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

by Correll Christoph, Zhu Baojin, Ascher-Svanum Haya, Faries Douglas, Kane John
Published 2005-05-01

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

by Montgomery William, Faries Douglas, Peng Xiaomei, Ascher-Svanum Haya, Haddad Peter M
Published 2009-07-01

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics

by Osuntokun Olawale, Ascher-Svanum Haya, Liu-Seifert Hong, Jen Kai, Gomez Juan
Published 2011-05-01

Item response analysis of the Positive and Negative Syndrome Scale

by Lindenmayer Jean-Pierre, Ascher-Svanum Haya, Santor Darcy A, Obenchain Robert L
Published 2007-11-01

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

by Nyhuis Allen W, Ascher-Svanum Haya, Faries Douglas E, Kinon Bruce J
Published 2009-09-01

Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

by Furiak Nicolas M, Faries Douglas E, Zhu Baojin, Ascher-Svanum Haya, Montgomery William
Published 2009-01-01

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study

by Ascher-Svanum Haya, Milton Denái R, Cuyún Carter Gebra B, Faries Douglas E
Published 2011-08-01

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

by Swartz Marvin, Landbloom Ron, Faries Douglas, Zhu Baojin, Ascher-Svanum Haya, Swanson Jeff
Published 2006-02-01

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

by Correll Christoph U, Faries Douglas E, Ascher-Svanum Haya, Zhu Baojin, Kane John M
Published 2008-04-01

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration

by Zhao Yingnan, Chiang Yi-Ju, Ascher-Svanum Haya, Shi Lizheng, Fonseca Vivian, Winstead Daniel
Published 2009-12-01

Costs of treating patients with schizophrenia who have illness-related crisis events

by Peng Xiaomei, Faries Douglas E, Ascher-Svanum Haya, Zhu Baojin, Salkever David, Slade Eric P
Published 2008-08-01

Predictors of switching antipsychotic medications in the treatment of schizophrenia

by Stauffer Virginia L, Ascher-Svanum Haya, Faries Douglas E, Nyhuis Allen W, Kinon Bruce J
Published 2010-09-01

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

by Faries Douglas E, Nyhuis Allen W, Ascher-Svanum Haya, Ball Daniel E, Kinon Bruce J
Published 2010-01-01

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

by Faries Douglas, Ascher-Svanum Haya, Phillips Glenn, Nyhuis Allen W, Sugihara Tomoko, Stauffer Virginia, Kinon Bruce J
Published 2012-09-01

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

by Slade Eric P, Salkever David, Faries Douglas E, Zhu Baojin, Ascher-Svanum Haya, Peng Xiaomei, Conley Robert R
Published 2010-01-01

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

by Haynes Virginia S, Zhu Baojin, Stauffer Virginia L, Kinon Bruce J, Stensland Michael D, Xu Lei, Ascher-Svanum Haya
Published 2012-12-01

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial

by Chen Lei, Phillips Glenn, Johnston Joseph, Kinon Bruce J, Ascher-Svanum Haya, Kollack-Walker Sara, Succop Paul, Naber Dieter
Published 2011-12-01